Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DE BEAUMER : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE BEAUMER is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTS (37260), this company of category PME shows in 2025 a net income positive of 70 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE BEAUMER (SIREN 811997311)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 69 518 € 68 086 € 110 027 € 140 905 € 115 955 € 130 406 € 108 643 € 127 441 € 112 081 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE DE BEAUMER generates positive net income of 70 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 112 k€ -> 70 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

69 518 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 39%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

39.061%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

61.312%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

48.0%

Solvency indicators evolution
SELARL PHARMACIE DE BEAUMER

Sector positioning

Debt ratio
39.06 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good -9 pts over 3 years

In 2025, the debt ratio of SELARL PHARMACIE DE BEAUMER (39.06) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
61.31% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +6 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE DE BEAUMER (61.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 160.37. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

160.371

Liquidity indicators evolution
SELARL PHARMACIE DE BEAUMER

Sector positioning

Liquidity ratio
160.37 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average -20 pts over 3 years

In 2025, the liquidity ratio of SELARL PHARMACIE DE BEAUMER (160.37) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELARL PHARMACIE DE BEAUMER in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE DE BEAUMER is estimated at 1 104 301 € (range 749 384€ - 1 732 801€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
749k€ 1104k€ 1732k€
1 104 301 € Range: 749 384€ - 1 732 801€
NAF 5 année 2025

Valuation method used

Net Income Multiple
69 518 € × 15.9x = 1 104 302 €
Range: 749 384€ - 1 732 801€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE BEAUMER with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DE BEAUMER

What is the revenue of SELARL PHARMACIE DE BEAUMER ?

The revenue of SELARL PHARMACIE DE BEAUMER is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DE BEAUMER profitable?

Yes, SELARL PHARMACIE DE BEAUMER generated a net profit of 70 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE DE BEAUMER ?

The headquarters of SELARL PHARMACIE DE BEAUMER is located in MONTS (37260), in the department Indre-et-Loire.

Where to find the tax return of SELARL PHARMACIE DE BEAUMER ?

The tax return of SELARL PHARMACIE DE BEAUMER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE BEAUMER operate?

SELARL PHARMACIE DE BEAUMER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.